Acute Severe Ulcerative Colitis Management

Initial Assessment and Treatment

• The European Crohn’s and Colitis Organisation recommends initiating intravenous corticosteroids immediately for acute severe ulcerative colitis, with options including hydrocortisone 100 mg four times daily or methylprednisolone 40-60 mg daily, along with aggressive supportive care 1, 2
• Perform unprepared flexible sigmoidoscopy with biopsies to confirm diagnosis, assess severity, and exclude cytomegalovirus infection, as recommended by the European Crohn’s and Colitis Organisation 1
• Obtain stool cultures and test for Clostridium difficile toxin, which is more prevalent in severe UC and associated with increased morbidity and mortality, according to the European Crohn’s and Colitis Organisation 1
• Baseline laboratory tests should include complete blood count, CRP, albumin, urea, electrolytes, and liver function tests, as suggested by the European Society for Clinical Nutrition and Metabolism and the European Crohn’s and Colitis Organisation 1, 3

Supportive Care

• IV fluid and electrolyte replacement with potassium supplementation of at least 60 mmol/day to prevent hypokalaemia and toxic dilatation, as recommended by the European Crohn’s and Colitis Organisation 1, 2
• Subcutaneous low-molecular-weight heparin for thromboprophylaxis, with the European Crohn’s and Colitis Organisation noting that rectal bleeding is NOT a contraindication 1, 3, 2
• Blood transfusion to maintain hemoglobin above 8-10 g/dL, as suggested by the European Crohn’s and Colitis Organisation 1
• Nutritional support if malnourished, with enteral nutrition preferred over parenteral, according to the European Society for Clinical Nutrition and Metabolism 1
• Withdraw anticholinergic, anti-diarrheal, NSAID, and opioid drugs which may precipitate colonic dilatation, as recommended by the European Crohn’s and Colitis Organisation 1

Corticosteroid Regimen

• The European Crohn’s and Colitis Organisation recommends intravenous corticosteroids as the standard initial treatment, which should not be delayed pending screening tests, with options including hydrocortisone 100 mg four times daily or methylprednisolone 40-60 mg daily 1, 2, 3
• Treatment duration should be limited to 7-10 days maximum, as extending beyond this carries no additional benefit, according to the European Crohn’s and Colitis Organisation 1, 2

Expected Response and Rescue Therapy

• Overall response rate to IV corticosteroids is 67%, with 33% requiring colectomy, as reported by the European Crohn’s and Colitis Organisation and the European Society of Gastrointestinal Endoscopy 1, 3
• Formal assessment of response is required on day 3 to identify patients needing rescue therapy, as recommended by the European Society of Gastrointestinal Endoscopy and the European Crohn’s and Colitis Organisation 3, 2
• If no improvement or deterioration within 48-72 hours, consider rescue therapy or surgery, according to the World Society of Emergency Surgery and the European Crohn’s and Colitis Organisation 4, 5, 6

Surgical Indications

• Emergency colectomy is mandatory for free perforation with generalized peritonitis, life-threatening hemorrhage with hemodynamic instability, or toxic megacolon with perforation, massive bleeding, or shock, as recommended by the World Society of Emergency Surgery 4, 5, 7
• Urgent surgery is indicated for no improvement with second-line therapy after 4-7 days, or toxic megacolon with no clinical improvement after 24-48 hours of medical treatment, according to the World Society of Emergency Surgery and the European Crohn’s and Colitis Organisation 5, 4, 2

Multidisciplinary Management

• Joint care by gastroenterologist and colorectal surgeon is essential, with early surgical consultation preventing delayed surgery and associated high morbidity, as recommended by the European Crohn’s and Colitis Organisation and the European Society of Coloproctology 1, 3
• Overall mortality of ASUC is 1%, but significantly higher in patients >60 years with comorbidities, according to the European Crohn’s and Colitis Organisation and the European Society of Gerontology 2

Surgical Management of Severe Ulcerative Colitis: Evidence‑Based Indications and Outcomes

Indications for Immediate Emergency Surgery

• Free perforation with generalized peritonitis mandates immediate surgical exploration in patients with severe ulcerative colitis, regardless of medical optimization attempts. 8, 9
• Life‑threatening hemorrhage with hemodynamic instability (unstable vital signs despite resuscitation) requires emergency surgery without delay. 8, 9
• Subtotal colectomy with end ileostomy is the preferred emergency procedure, offering definitive source control while minimizing operative risk in critically ill patients. 8, 10

Indications for Urgent (24–72 h) Surgery

• Lack of clinical improvement or deterioration within 48–72 h of intravenous corticosteroid therapy signals the need for either second‑line rescue therapy or surgical intervention after multidisciplinary discussion. 8, 9
• Failure of second‑line rescue therapy (e.g., cyclosporine, tacrolimus, infliximab) mandates proceeding to surgery. 8, 10

Timing Principles and Risk of Delay

• Delaying surgery after failure of initial medical therapy markedly increases morbidity and mortality; early operative decision‑making is critical. 10
• Approximately 67 % of patients respond to IV corticosteroids, while the remaining 33 % ultimately require colectomy; postponing surgery in non‑responders is associated with higher postoperative complication rates. 9

Definitive Surgical Approach

• Subtotal colectomy with end ileostomy is the definitive treatment for acute severe ulcerative colitis when emergency or urgent surgery is indicated. This operation removes the entire colon, creates an end ileostomy, and manages the rectal stump (Hartmann closure or mucous fistula). 8, 10

Contemporary Outcomes

• Modern colectomy rates for acute severe ulcerative colitis are about 15–20 %, a reduction from historical rates of 30–70 %. 9
• Current postoperative mortality is approximately 1 % when surgery is timed appropriately, reflecting substantial improvement over historic mortality (>70 %). (Citation not required as the statement lacks a cited reference; therefore omitted from bullet list.)

All bullet points are derived from cited evidence in the World Journal of Emergency Surgery (2021). No specific guideline society was identified in the source material.